Search for data related to genes or regions
+
97 Study Datasets reported containing markers in gene or region ADAM19 (no 5′ and no 3′ flanks) with -log p ≥ 0 (showing 1-50)
Pages: 1 2
No data sets (in No Phenotypes) added to Browser
Phenotype tested in Study Phenotype ontology annotation Total p-values in Study StudyAdd data sets to Browser Related Study data
4 kHz hearing threshold (HGVPM567)
  • Hearing
959,443 GWAS of 4 kHz hearing threshold in a British population (HGVST311)
Adult height (HGVPM565)
  • Body Height
959,443 GWAS of height in a British population (HGVST309)
Age-related macular degeneration (HGVPM6)
  • Macular Degeneration
427,832 GWAS of age-related macular degeneration (HGVST4)
Age-related macular degeneration (HGVPM771)
  • Macular Degeneration
324,071 GWAS of age-related macular degeneration (HGVST435)
Alzheimer's disease (HGVPM72)
  • Alzheimer Disease
1,485,632 GWAS of Alzheimer's disease (HGVST51)
Amyotrophic lateral sclerosis (HGVPM96)
  • Amyotrophic Lateral Sclerosis
513,910 GWAS of amyotrophic lateral sclerosis (HGVST65)
Amyotrophic lateral sclerosis (HGVPM40)
  • Amyotrophic Lateral Sclerosis
512,052 GWAS of sporadic amyotrophic lateral sclerosis in a homogenous Irish population (HGVST29)
Anti-cyclic citrullinated peptide-positive rheumatoid arthritis (HGVPM38)
  • Arthritis, Rheumatoid
297,085 GWAS of rheumatoid arthritis (HGVST27)
Asthma (HGVPM1101)
  • Asthma
1,636,822 GWAS of asthma (HGVST631)
Bipolar disorder (HGVPM1512)
  • Bipolar Disorder
699,461 Whole Genome Association Study of bipolar disorder (HGVST889)
Bipolar disorder (HGVPM1513)
  • Bipolar Disorder
809,854 Whole Genome Association Study of bipolar disorder (HGVST889)
Bipolar disorder (HGVPM837)
  • Bipolar Disorder
1,509,315 GWAS of bipolar disorder in European American and African American individuals (HGVST472)
Bipolar disorder (body mass index interaction) (HGVPM3900)
  • Bipolar Disorder
51 GWAS of Bipolar disorder (HGVST1906)
Birth weight (HGVPM571)
  • Birth Weight
959,443 GWAS of birth weight in a British population (HGVST315)
Blood protein levels (HGVPM7473)
  • Blood Proteins
1,003 GWAS of Blood proteins (HGVST3734)
Body mass index (HGVPM1111)
  • Body Mass Index
2,471,541 GWAS of body mass index (HGVST640)
Body mass index (HGVPM564)
  • Body Mass Index
959,443 GWAS of adult body mass index in a British population (HGVST308)
Brain glutamate concentrations (HGVPM1065)
  • Glutamic Acid
  • Multiple Sclerosis
  • Brain
501,855 GWAS of patients with multiple sclerosis using brain glutamate concentration as a quantitative trait (HGVST605)
Breast cancer (HGVPM2)
  • Breast Neoplasms
1,602,688 GWAS of breast cancer (HGVST2)
Chin protrusion (2) (HGVPM10385)
  • Chin
11,868 GWAS of Facial morphology (HGVST4323)
Chronic obstructive pulmonary disease (HGVPM13561)
  • Pulmonary Disease, Chronic Obstructive
35 GWAS of Chronic obstructive pulmonary disease (HGVST4948)
Chronic obstructive pulmonary disease (HGVPM6400)
  • Pulmonary Disease, Chronic Obstructive
31 GWAS of Chronic obstructive pulmonary disease (HGVST3281)
Chronic obstructive pulmonary disease (HGVPM7383)
  • Pulmonary Disease, Chronic Obstructive
124 GWAS of Chronic obstructive pulmonary disease (HGVST3694)
Chronic obstructive pulmonary disease in never smokers (HGVPM11630)
  • Pulmonary Disease, Chronic Obstructive
32 GWAS of Chronic obstructive pulmonary disease (HGVST4488)
Chronic obstructive pulmonary disease in non-current smokers (HGVPM11633)
  • Pulmonary Disease, Chronic Obstructive
54 GWAS of Chronic obstructive pulmonary disease (HGVST4488)
Chronic obstructive pulmonary disease x current smoker interaction (2df) (HGVPM11627)
  • Pulmonary Disease, Chronic Obstructive
55 GWAS of Chronic obstructive pulmonary disease (HGVST4488)
Chronic obstructive pulmonary disease x current smoker interaction (main effect) (HGVPM11631)
  • Pulmonary Disease, Chronic Obstructive
54 GWAS of Chronic obstructive pulmonary disease (HGVST4488)
Chronic obstructive pulmonary disease x ever smoker interaction (2df) (HGVPM11636)
  • Pulmonary Disease, Chronic Obstructive
48 GWAS of Chronic obstructive pulmonary disease (HGVST4488)
Chronic obstructive pulmonary disease x ever smoker interaction (main effect) (HGVPM11632)
  • Pulmonary Disease, Chronic Obstructive
32 GWAS of Chronic obstructive pulmonary disease (HGVST4488)
Coronary artery disease (HGVPM113)
  • Coronary Artery Disease
1,059 GWAS of coronary artery disease (HGVST75)
Crohn's disease (HGVPM1169)
  • Crohn Disease
953,239 GWAS of Crohn's disease (HGVST680)
Diabetic nephropathy in type I diabetes (HGVPM1531)
  • Diabetic Nephropathies
706,749 Genetics of kidneys in diabetes (GoKinD) (HGVST890)
Diabetic nephropathy in type I diabetes (HGVPM1524)
  • Diabetic Nephropathies
358,475 Genetics of kidneys in diabetes (GoKinD) (HGVST890)
Eosinophil percentage of white cells (HGVPM13465)
  • Eosinophils
599 GWAS of Blood traits (HGVST4908)
Ethanol (HGVPM3609)
  • Ethanol
2,479 GWAS of Metabolite quantitative traits (HGVST1827)
Eye color (HGVPM6470)
  • Eye Color
26,116 GWAS of Skin pigmentation (HGVST3308)
Fasting glucose-related: fasting plasma glucose (HGVPM825)
  • Blood Glucose
2,470,479 GWAS of glycemic traits (HGVST463)
Fasting glucose-related: homeostatic model assessment of beta-cell function (HGVPM827)
  • Insulin-Secreting Cells
2,456,942 GWAS of glycemic traits (HGVST463)
Fasting insulin-related: fasting insulin (HGVPM822)
  • Insulin
2,461,093 GWAS of glycemic traits (HGVST463)
Fasting insulin-related: homeostatic model assessment of insulin resistance (HGVPM826)
  • Insulin Resistance
2,458,062 GWAS of glycemic traits (HGVST463)
FEV1 (HGVPM7100)
  • Forced Expiratory Volume
206 GWAS of Lung function (HGVST3580)
Flucloxacillin-induced liver injury (HGVPM153)
  • Chemical and Drug Induced Liver Injury
1,736,660 GWAS of drug-induced liver injury due to flucloxacillin (HGVST107)
Forced expiratory volume (HGVPM916)
  • Forced Expiratory Volume
3,000 GWAS of lung function (HGVST513)
Forced expiratory volume in one second/forced vital capacity ratio (HGVPM898)
  • Forced Expiratory Volume
7 Meta-analysis of pulmonary function (HGVST498)
Glycated hemoglobin levels (HGVPM1081)
  • Glycated Hemoglobin A
2,565,330 GWAS of glycated hemoglobin levels (HGVST618)
Height (HGVPM1104)
  • Body Height
2,469,669 GWAS of height (HGVST634)
Height-adjusted highest forced expiratory volume (HGVPM566)
  • Forced Expiratory Volume
959,443 GWAS of height-adjusted highest forced expiratory volume in a British population (HGVST310)
Hodgkin lymphoma (HGVPM3588)
  • Hodgkin Disease
584,850 GWAS of Hodgkin lymphoma (HGVST1823)
Inflammatory skin disease (HGVPM4501)
  • Psoriasis
88 GWAS of Atopic dermatitis and psoriasis (HGVST2270)
Ischemic stroke (HGVPM20)
  • Stroke
786,560 GWAS of ischemic stroke (HGVST14)